Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:5431021.
doi: 10.1155/2016/5431021. Epub 2016 Jan 28.

Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation

Affiliations

Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation

Maryam Najafi et al. J Ophthalmol. 2016.

Abstract

Purpose. Pterygium is a serious eye problem in countries with high exposure to UV. However, despite numerous studies, the molecular etiology of pterygium is unclear. Recent studies have indicated that LATS1 and LATS2 genes are involved in DDR signaling pathways against continuous UV exposure. Our aim was to evaluate the LATS1 and LATS2 promoter methylation with the risk of pterygium formation. Methods. We evaluated the promoter methylation status of LATS1 and LATS2 using methylation-specific PCR technique. Also, mRNA expression of LATS1 and LATS2 was assessed in 14 cases of pterygium and 14 normal specimens by real-time PCR. Results. Promoter methylation of LATS1 and LATS2 was detected significantly between pterygium tissues and normal tissues [LATS1; OR = 4.9; 95% CI: 1.54 to 15.48, P = 0.003; LATS2; OR = 7.1; 95% CI: 1.53 to 33.19, P = 0.004]. The gene expression analysis showed a statistically significant difference between pterygium tissues and healthy controls for both LATS1 and LATS2 (P < 0.05). Conclusions. The data of this study is the first report regarding the effect of promoter methylation of the LATS1 and LATS2 in the pterygium. To confirm these data, doing further studies in various genetic populations with large sample sizes using advanced molecular techniques is proposed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pterygium.
Figure 2
Figure 2
Representative results of methylation-specific PCR analysis of LATS1 (a) and LATS2 (b) in random pterygium tissues (T). M, methylated; U, unmethylated. Marker, 50 bp size marker.

Similar articles

Cited by

References

    1. Jiao W., Zhou C., Wang T., et al. Prevalence and risk factors for pterygium in rural older adults in Shandong Province of China: a cross-sectional study. BioMed Research International. 2014;2014:8. doi: 10.1155/2014/658648.658648 - DOI - PMC - PubMed
    1. Zheng K., Cai J., Jhanji V., Chen H. Comparison of pterygium recurrence rates after limbal conjunctival autograft transplantation and other techniques: meta-analysis. Cornea. 2012;31(12):1422–1427. doi: 10.1097/ico.0b013e31823cbecb. - DOI - PubMed
    1. Akhter W., Tayyab A., Kausar A., Masrur A. Reducing postoperative pterygium recurrence: comparison of free conjunctival auto-graft and conjunctival rotation flap techniques. Journal of the College of Physicians and Surgeons Pakistan. 2014;24(10):740–744. - PubMed
    1. Cardenas-Cantu E., Zavala J., Valenzuela J., Valdez-García J. E. Molecular basis of pterygium development. Seminars in Ophthalmology. 2014 doi: 10.3109/08820538.2014.971822. - DOI - PubMed
    1. Takahashi Y., Miyoshi Y., Takahata C., et al. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clinical Cancer Research. 2005;11(4):1380–1385. doi: 10.1158/1078-0432.CCR-04-1773. - DOI - PubMed

LinkOut - more resources